The Effect of Brushing With Salvadorapersica (Miswak) Sticks on Salivary Streptococcus Mutants and Plaque Level in Children: A Clinical Trial

Plaque, Dental Clinical Trial

Official title:

The Effect of Brushing With Salvadorapersica (Miswak) Sticks on Salivary Streptococcus Mutants and Plaque Level in Children: A Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04137393
• Other study ID #: 006-16
• Status: Completed
• Phase: Phase 3
• Start date: October 2016
• Est. completion date: June 2018

Study information

• Verified date: October 2019
• Source: King Abdulaziz University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Objectives:

to evaluate the effect of brushing with Salvadora persica (Miswak) on streptococcus mutants compared to brushing with fluoridated tooth paste (FTP) in children.

Methods:

A total of 94 healthy children (8 years old) from an elementary governmental school in Jeddah, Saudi Arabia were grouped to Miswak and FTP groups. They were assessed for their salivary level of mutans streptococci species, and lactobacillus at the baseline and three weeks after brushing. Caries level using DMFT/dmft, and plaque amount using Greene Vermillion simplified oral hygiene index were recorded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: June 2018
• Est. primary completion date: October 2017
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 8 Years to 9 Years

Eligibility

Inclusion Criteria:

• Healthy children

• age from 8 to 9

• parents signed the consent form they attended morning session for brushing

Exclusion Criteria:

• medical compromised children

• parents did not sign the consent form Did not attend morning session

Related Conditions & MeSH terms

• Dental Plaque
• Plaque, Dental

Intervention

Combination Product:
• brushing
mechanical and chemical plaque removal

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Heba sabbagh

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	green and vermillion	plaque level	4 months